NCT07221955

The Impact of Qualia Gluthathione+ on Blood Glutathione Levels

• Status: Not Yet Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 54 (estimated)
• Sponsor: Qualia Life Sciences · Industry
• Sex: All
• Age: 45 Years – 75 Years
• Healthy volunteers: Accepted

Summary

This is a randomized, double-blind, placebo-controlled, parallel-group, triple-armed, study evaluating the effects of two distinct Qualia Glutathione+ formulations on Whole Blood Glutathione levels in the blood of healthy adults aged 45-75 years. Approximately 18 participants will be randomized to one of three study arms: Qualia Glutathione+ version 1, Qualia Glutathione+ version 2, or placebo. Each participant will take two or three capsules of their assigned product once daily in the morning, with or without food, over a 20-day period. The primary outcome is the change in blood glutathione levels, assessed via in lab blood collection at baseline and study completion. Secondary endpoints include questionnaires measuring health-related quality of life, fatigue, and cognitive functioning (PROMIS Global Health-10, PROMIS Short Form v1.0 - Fatigue 10a, PROMIS Cognitive Function - Short Form 8a), evaluation of safety and tolerability, and an Overall Experience Questionnaire (Appendices 1, 4-7). All assessments, including electronic questionnaires, are completed remotely without in-person visits.

Conditions

• Effects of Qualia Glutathione+ on Blood Glutathione Levels
• Glutathione

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Qualia Glutathione+ version 1	Qualia Glutathione+ version 1 manufactured by Qualia Life Sciences
DIETARY_SUPPLEMENT	Qualia Glutathione+ version 2	Qualia Glutathione+ version 2 manufactured by Qualia Life Sciences
DIETARY_SUPPLEMENT	Placebo	Rice flour

Timeline

• Start date: 2025-12-02
• Primary completion: 2025-12-22
• Completion: 2026-01-25
• First posted: 2025-10-29
• Last updated: 2025-11-14

Locations

1 site across 1 country: United States